Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
EQS-News: Biotest AG / Key word: 9 Month figures Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023 02.11.2023 / 08:00 CET/CEST The issuer...
Stay updated with breaking news from Igg Next Generation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Biotest AG / Key word: 9 Month figures Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023 02.11.2023 / 08:00 CET/CEST The issuer...
EQS-News: Biotest AG / Key word: Regulatory Approval Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK 21.09.2023 / 09:00...
EQS-News: Biotest AG / Key word: Regulatory Admission Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin...
EQS-News: Biotest AG / Key word: Half Year Report Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023 10.08.2023 / 09:00... -Today at 03:01 am- MarketScreener
EQS-News: Biotest AG / Key word(s): Half Year Report Biotest AG: Biotest increases EBIT to Euro 19.8 million in th...